Yunmeng Nie
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dihydrotanshinone I suppresses glycolysis and gastric cancer growth by targeting the nuclear FBXW11/LTN1/PKM2 axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 26, 2025
Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: September 15, 2025
Quzhou-sourced Fructus Aurantii ameliorates MASLD by modulating glycolysis-dependent M1 polarization in hepatic macrophages.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 13, 2025
Letter: MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls.
Journal: Alimentary pharmacology & therapeutics
Published: October 25, 2024
Letter: Bisphosphonate effectiveness in patients with cirrhosis-An emulated clinical trial.
Journal: Alimentary pharmacology & therapeutics
Published: September 10, 2024
FIT-Positive Individuals: Is Timely Upper GI Endoscopy Necessary?
Journal: Gastroenterology
Published: August 23, 2024
Mechanistic study of fructus aurantii (Quzhou origin) in regulating ileal reg3g in the treatment for NASH.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 06, 2024
Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 24, 2023
The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experiments.
Journal: Frontiers in pharmacology
Published: November 09, 2022
The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 20, 2022
Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.
Journal: Journal of immunology research
Published: February 09, 2022
Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota.
Journal: Frontiers in cellular and infection microbiology
Published: November 29, 2021
Last Updated: 09/26/2026